|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1993-3-22
|
|
pubmed:abstractText |
Previous studies have reported that cis-diamminedichloroplatinum (II) (CDDP) exhibits various immunomodulating activities. The current study investigates the effect of CDDP on the susceptibility of K562 cells to lysis by peripheral blood lymphocytes (PBL), natural killer (NK) cells, and lymphokine activated killer (LAK) cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Surface,
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Chloroquine,
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Dipeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Interferons,
http://linkedlifedata.com/resource/pubmed/chemical/Killer Factors, Yeast,
http://linkedlifedata.com/resource/pubmed/chemical/Lymphokines,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/leucyl-leucine-methyl ester,
http://linkedlifedata.com/resource/pubmed/chemical/transplatin
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1313-21
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7679609-Aged,
pubmed-meshheading:7679609-Aged, 80 and over,
pubmed-meshheading:7679609-Antigens, Neoplasm,
pubmed-meshheading:7679609-Antigens, Surface,
pubmed-meshheading:7679609-Carboplatin,
pubmed-meshheading:7679609-Chloroquine,
pubmed-meshheading:7679609-Cisplatin,
pubmed-meshheading:7679609-Cytotoxicity, Immunologic,
pubmed-meshheading:7679609-Dipeptides,
pubmed-meshheading:7679609-Female,
pubmed-meshheading:7679609-Humans,
pubmed-meshheading:7679609-Immunosuppressive Agents,
pubmed-meshheading:7679609-Interferons,
pubmed-meshheading:7679609-Killer Cells, Lymphokine-Activated,
pubmed-meshheading:7679609-Killer Cells, Natural,
pubmed-meshheading:7679609-Killer Factors, Yeast,
pubmed-meshheading:7679609-Leukemia, Erythroblastic, Acute,
pubmed-meshheading:7679609-Lymphokines,
pubmed-meshheading:7679609-Male,
pubmed-meshheading:7679609-Middle Aged,
pubmed-meshheading:7679609-Proteins,
pubmed-meshheading:7679609-Stereoisomerism,
pubmed-meshheading:7679609-T-Lymphocytes,
pubmed-meshheading:7679609-Tumor Cells, Cultured,
pubmed-meshheading:7679609-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
|
|
pubmed:affiliation |
Department of Urology, Faculty of Medicine, Kyoto University, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
